Expansion rates of small abdominal aortic aneurysms
- PMID: 9440450
- DOI: 10.1111/j.1445-2197.1998.tb04630.x
Expansion rates of small abdominal aortic aneurysms
Abstract
Background: The present study was carried out in order to examine those factors that influence the rate of expansion of small abdominal aortic aneurysms.
Methods: A retrospective study was undertaken of 112 patients who attended the St George Vascular Laboratory between 1987 and 1997. These patients had abdominal aortic aneurysms that were considered to be too small to warrant surgical repair at the time of presentation. Sequential ultrasound examinations were used to measure maximal anteroposterior aneurysm diameter. From these data, annual growth rates were calculated. Growth rate per annum was then compared with gender, age, initial aortic aneurysm diameter, presence of hypertensive disease, cardiac disease, family history of aneurysmal disease, diabetes mellitus, smoking, beta-adrenergic blockade and lipid lowering drugs.
Results: Univariate analysis showed that three factors were significantly related to growth rate: the initial size of the aortic aneurysm, the presence of cardiac disease and the presence of beta-adrenergic blockade.
Conclusions: The presence of beta-adrenergic blockade appeared to have an independent effect on aneurysm growth rate, and suggests a possible role for beta-adrenergic blockade as a therapeutic strategy in controlling expansion rates of small abdominal aortic aneurysms. A controlled double-blind clinical trial is required to demonstrate this conclusively.
Similar articles
-
Abdominal aortic aneurysm expansion rate: effect of size and beta-adrenergic blockade.J Vasc Surg. 1994 Apr;19(4):727-31. doi: 10.1016/s0741-5214(94)70048-6. J Vasc Surg. 1994. PMID: 7909340
-
Risk factors associated with late aneurysmal sac expansion after endovascular abdominal aortic aneurysm repair.Diagn Interv Radiol. 2015 May-Jun;21(3):195-201. doi: 10.5152/dir.2014.14308. Diagn Interv Radiol. 2015. PMID: 25858524 Free PMC article.
-
Medical management of small abdominal aortic aneurysms.Circulation. 2008 Apr 8;117(14):1883-9. doi: 10.1161/CIRCULATIONAHA.107.735274. Circulation. 2008. PMID: 18391122 Free PMC article. Review.
-
Factors associated with small abdominal aortic aneurysm expansion rate.JAMA Surg. 2015 Jan;150(1):44-50. doi: 10.1001/jamasurg.2014.2025. JAMA Surg. 2015. PMID: 25389641
-
Pharmacotherapy of abdominal aortic aneurysms.Curr Vasc Pharmacol. 2006 Apr;4(2):129-49. doi: 10.2174/157016106776359817. Curr Vasc Pharmacol. 2006. PMID: 16611155 Review.
Cited by
-
Assessment of pre-operative delays in the management of elective abdominal aortic aneurysms.Ann R Coll Surg Engl. 2008 Jan;90(1):65-8. doi: 10.1308/003588408X242088. Ann R Coll Surg Engl. 2008. PMID: 18201505 Free PMC article.
-
The efficacy of pharmacotherapy for decreasing the expansion rate of abdominal aortic aneurysms: a systematic review and meta-analysis.PLoS One. 2008 Mar 26;3(3):e1895. doi: 10.1371/journal.pone.0001895. PLoS One. 2008. PMID: 18365027 Free PMC article.
-
Growth rates of small abdominal aortic aneurysms correlate with clinical events.Br J Surg. 2010 Jan;97(1):37-44. doi: 10.1002/bjs.6779. Br J Surg. 2010. PMID: 20013940 Free PMC article.
-
Beta-Blockers and Abdominal Aortic Aneurysm Growth: A Systematic Review and Meta-Analysis.Curr Cardiol Rev. 2021;17(4):e230421187502. doi: 10.2174/1573403X16999201102213619. Curr Cardiol Rev. 2021. PMID: 33143615 Free PMC article.
-
Development of pharmacotherapies for abdominal aortic aneurysms.Biomed Pharmacother. 2022 Sep;153:113340. doi: 10.1016/j.biopha.2022.113340. Epub 2022 Jun 30. Biomed Pharmacother. 2022. PMID: 35780618 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources